Cost effectiveness of palivizumab in Spain: an analysis using observational data

OBJECTIVES: To assess the cost effectiveness of palivizumab for prevention of severe respiratory syncytial virus (RSV) disease in high-risk infants in Spain, incorporating country-specific observational hospitalisation data. METHODS: An existing decision tree model, designed using data from a large...

Descripción completa

Detalles Bibliográficos
Autores principales: Nuijten, Mark J., Wittenberg, Wolfgang
Formato: Texto
Lenguaje:English
Publicado: Springer-Verlag 2009
Materias:
Original Paper
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816247/
https://www.ncbi.nlm.nih.gov/pubmed/19967425
http://dx.doi.org/10.1007/s10198-009-0206-x

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2816247/
https://www.ncbi.nlm.nih.gov/pubmed/19967425
http://dx.doi.org/10.1007/s10198-009-0206-x

Ejemplares similares